Page last updated: 2024-08-21

levonorgestrel and tamoxifen

levonorgestrel has been researched along with tamoxifen in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (8.33)	18.7374
1990's	1 (2.78)	18.2507
2000's	15 (41.67)	29.6817
2010's	15 (41.67)	24.3611
2020's	2 (5.56)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Kulcsár, A; Kulcsár-Gergely, J	1
Bayard, F; Dupont, MA; Gas, N; Jozan, S; Roubinet, F; Valette, A	1
Bayard, F; David, JF; Faye, JC; Jozan, S; Tauber, JP; Tournier, JF	1
Bayard, F; Jozan, S; Kreitmann, B	1
Neven, P	1
Abrams, KR; Al-Azzawi, F; Bell, SC; Brown, LJ; Gardner, FJ; Khanna, S; Konje, JC; Taylor, DJ	1
Cohen, I	1
Friese, K; Gerber, B; Krause, A; Müller, H; Reimer, T	1
Avari, KM; Bhiwgade, DA; Borkar, MR	1
Espié, M	1
Abdel-Aleem, AM; Abdel-Aleem, H; Amin, AF; Shaaban, OM	1
Boutet, G	1
Chan, SS; Kwan, WH; Ng, DP; Tam, WH; Wong, AW; Yeo, W; Yu, MM; Yuen, PM	1
Atis, A; Aydin, Y; Kesim, MD; Mandiraci, G	1
Bentolila, J; Boisserie-Lacroix, M; Bouzgarrou, M; Cavagni, P; Laumonier, H; Lebiez-Michel, N; Trillaud, H	1
Abrams, KR; Bell, SC; Brown, LJ; Gardner, FJ; Habiba, M; Konje, JC; Taylor, DJ	1
Chin, J; Hickey, M; Konje, JC	1
Patel, A; Schwarz, EB	1
Alfhaily, F; Ewies, AA	1
Soper, DE	1
Chan, SSC; Tam, WH; Wong, AWY; Yeo, W; Yu, MY	1
Ancona, E; Bertocco, A; D'Antona, D; Di Gangi, S; Fagherazzi, S; Gizzo, S; Nardelli, GB; Noventa, M; Patrelli, TS; Saccardi, C	1
Fu, Y; Zhuang, Z	1
Li, J; Li, M; Shi, Q; Wu, J; Xing, A; Yao, Q	1
Crane, EK; Eskew, AM	1
Chin, J; Dominick, S; Hickey, M; Su, HI	1
Bóta, J; Csányi, A; Ducza, E; Falkay, G; Gáspár, R	1
Azuri, J; Bachar, R; Bialik, M; Katzir, I; Landes, JV; Lomnicky, Y; Porath, A; Rabinovich, HR; Segal, Y; Siegelmann-Danieli, N	1
Habiba, M; Konje, JC; Philip, S; Taylor, AH	1
Cohen, MA; Edelman, AB; Jensen, JT; Simmons, KB	1
Ewies, A; Omar, OAM	1
Hickey, M; Romero, SA; Su, HI; Young, K	1

Reviews

10 review(s) available for levonorgestrel and tamoxifen

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?]. Gynecologie, obstetrique & fertilite, 2006, Volume: 34, Issue:11 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptive Agents, Female; Endometrial Neoplasms; Evidence-Based Medicine; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Tamoxifen	2006
[Hormones and mammographic breast density]. Journal de radiologie, 2008, Volume: 89, Issue:9 Pt 2 Topics: Adult; Aged; Biopsy; Breast; Breast Neoplasms; Contraceptive Agents, Female; Diagnosis, Differential; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Hormones; Humans; Intrauterine Devices; Levonorgestrel; Mammography; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Sensitivity and Specificity; Tamoxifen	2008
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen	2009
Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperplasia. Obstetrical & gynecological survey, 2012, Volume: 67, Issue:11 Topics: Administration, Oral; Breast Neoplasms; Contraceptive Agents, Female; Drug Therapy, Combination; Endometrial Hyperplasia; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Progesterone; Tamoxifen	2012
Levonorgestrel intrauterine system in adjuvant tamoxifen treatment: balance of breast risks and endometrial benefits--systematic review of literature. Reproductive sciences (Thousand Oaks, Calif.), 2014, Volume: 21, Issue:4 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Proliferation; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Patient Selection; Progesterone; Risk Assessment; Risk Factors; Tamoxifen; Time Factors; Treatment Outcome	2014
Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:10 Topics: Breast Neoplasms; Chi-Square Distribution; Endometrial Neoplasms; Endometrium; Estrogen Antagonists; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Odds Ratio; Polyps; Risk Factors; Tamoxifen; Treatment Outcome	2014
The role of levonorgestrel-releasing intrauterine system for endometrial protection in women with breast cancer taking tamoxifen. European journal of gynaecological oncology, 2014, Volume: 35, Issue:5 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices; Levonorgestrel; Tamoxifen	2014
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. The Cochrane database of systematic reviews, 2015, Dec-09, Issue:12 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen	2015
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. The Cochrane database of systematic reviews, 2020, 12-21, Volume: 12 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen; Uterine Hemorrhage; Uterus	2020

Trials

6 trial(s) available for levonorgestrel and tamoxifen

Article	Year
Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial. Lancet (London, England), 2000, Nov-18, Volume: 356, Issue:9243 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrium; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Patient Dropouts; Postmenopause; Tamoxifen; Treatment Outcome; Uterine Hemorrhage	2000
Tamoxifen treatment of bleeding irregularities associated with Norplant use. Contraception, 2005, Volume: 72, Issue:6 Topics: Adult; Double-Blind Method; Estrogen Antagonists; Female; Humans; Levonorgestrel; Placebos; Tamoxifen; Uterine Hemorrhage	2005
A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. BJOG : an international journal of obstetrics and gynaecology, 2007, Volume: 114, Issue:12 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Polyps; Postmenopause; Premenopause; Tamoxifen; Uterine Diseases	2007
Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial. Gynecologic oncology, 2009, Volume: 114, Issue:3 Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Polyps; Postmenopause; Tamoxifen; Ultrasonography; Uterine Diseases	2009
Prophylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial. Obstetrics and gynecology, 2013, Volume: 121, Issue:5 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Delivery Systems; Endometrial Hyperplasia; Female; Humans; Levonorgestrel; Middle Aged; Tamoxifen	2013
Tamoxifen for the prevention of unscheduled bleeding in new users of the levonorgestrel 52-mg intrauterine system: a randomized controlled trial. Contraception, 2019, Volume: 100, Issue:5 Topics: Adult; Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Linear Models; Metrorrhagia; Tamoxifen; Young Adult	2019

Other Studies

20 other study(ies) available for levonorgestrel and tamoxifen

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Effects of tamoxifen and levonorgestrel treatment on carbon tetrachloride induced alterations in rats. Arzneimittel-Forschung, 1991, Volume: 41, Issue:12 Topics: Aminopyrine N-Demethylase; Animals; Bilirubin; Body Water; Carbon Tetrachloride Poisoning; Cytochrome b Group; Cytochrome b6f Complex; Cytochrome P-450 Enzyme System; Levonorgestrel; Liver; Liver Cirrhosis, Experimental; Liver Glycogen; Male; Microsomes, Liver; Proteins; Rats; Rats, Inbred Strains; Tamoxifen	1991
Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events. Cancer research, 1987, Mar-15, Volume: 47, Issue:6 Topics: Breast Neoplasms; Carcinoma; Cell Division; Cell Line; Estradiol; Female; Humans; Interphase; Levonorgestrel; Norgestrel; Tamoxifen; Tetradecanoylphorbol Acetate	1987
Interaction of estradiol and high density lipoproteins on proliferation of the human breast cancer cell line MCF-7 adapted to grow in serum free conditions. Biochemical and biophysical research communications, 1985, Nov-27, Volume: 133, Issue:1 Topics: Breast Neoplasms; Cell Count; Cell Division; Cell Line; Culture Media; Drug Interactions; Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Tamoxifen; Thymidine; Tritium	1985
Different effects of oestradiol, oestriol, oestetrol and of oestrone on human breast cancer cells (MCF-7) in long term tissue culture. Acta endocrinologica, 1981, Volume: 98, Issue:1 Topics: Breast Neoplasms; Cell Division; Cell Line; Estetrol; Estradiol; Estriol; Estrone; Female; Humans; Levonorgestrel; Norgestrel; Progesterone; Receptors, Progesterone; Tamoxifen	1981
Local levonorgestrel to prevent tamoxifen-related endometrial lesions. Lancet (London, England), 2000, Nov-18, Volume: 356, Issue:9243 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Tamoxifen; Uterine Hemorrhage	2000
Levonorgestrel-releasing intrauterine devices. Lancet (London, England), 2001, Mar-10, Volume: 357, Issue:9258 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Postmenopause; Progesterone Congeners; Tamoxifen	2001
Levonorgestrel-releasing intrauterine devices. Lancet (London, England), 2001, Mar-10, Volume: 357, Issue:9258 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progesterone Congeners; Tamoxifen	2001
Fine structure of prolactin cell of female albino rat as affected by some antifertility drugs--a comparative electron microscopic study. Indian journal of experimental biology, 2001, Volume: 39, Issue:2 Topics: Animals; Contraceptive Agents; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Levonorgestrel; Microscopy, Electron; Norethindrone; Pituitary Gland; Progesterone; Prolactin; Rats; Rats, Wistar; Tamoxifen	2001
[Tamoxifen, endometrial cancer and levonorgestrel intra-uterine device]. Gynecologie, obstetrique & fertilite, 2003, Volume: 31, Issue:10 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Tamoxifen; Treatment Outcome	2003
ACOG committee opinion. No. 337: Noncontraceptive uses of the levonorgestrel intrauterine system. Obstetrics and gynecology, 2006, Volume: 107, Issue:6 Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Female; Humans; Hyperplasia; Intrauterine Devices; Levonorgestrel; Menorrhagia; Selective Estrogen Receptor Modulators; Tamoxifen	2006
Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen. Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:3 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptive Agents, Female; Drug Interactions; Endometrium; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipids; Middle Aged; Patient Compliance; Patient Satisfaction; Polyps; Postmenopause; Tamoxifen; Treatment Outcome; Uterine Diseases	2008
Cancer and contraception. Release date May 2012. SFP Guideline #20121. Contraception, 2012, Volume: 86, Issue:3 Topics: Anemia; Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraception; Contraceptive Agents, Female; Estrogens; Female; Humans; Immunosuppression Therapy; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasms; Osteoporosis; Progestins; Tamoxifen; Venous Thromboembolism	2012
The intrauterine device: a good thing revisited. Obstetrics and gynecology, 2013, Volume: 121, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Biomedical Research; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Metrorrhagia; Pelvic Inflammatory Disease; Tamoxifen; Tranexamic Acid	2013
Levonorgestrel Intrauterine Device Placement in a Premenopausal Breast Cancer Patient with a Bicornuate Uterus. Journal of minimally invasive gynecology, 2016, Volume: 23, Issue:1 Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Tamoxifen; Treatment Outcome; Urogenital Abnormalities; Uterine Hemorrhage; Uterus	2016
The Effects of Female Sexual Hormones on the Expression of Aquaporin 5 in the Late-Pregnant Rat Uterus. International journal of molecular sciences, 2016, Aug-22, Volume: 17, Issue:8 Topics: Animals; Aquaporin 5; Clomiphene; Estradiol; Estrogens; Female; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; Progesterone; Progestins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tamoxifen; Uterus	2016
Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective. Breast cancer research and treatment, 2018, Volume: 167, Issue:1 Topics: Adult; Breast Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Levonorgestrel; Middle Aged; Risk Factors; Tamoxifen; Trastuzumab	2018
The levonorgestrel-releasing intrauterine device induces endometrial decidualisation in women on tamoxifen. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2019, Volume: 39, Issue:8 Topics: Aged; Biomarkers; Breast Neoplasms; Decidua; Endometrium; Female; Humans; Immunohistochemistry; Insulin-Like Growth Factor Binding Protein 1; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Postmenopause; Tamoxifen	2019
Re: The levonorgestrel-releasing intrauterine device induces endometrial decidualisation in women on tamoxifen. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2021, Volume: 41, Issue:2 Topics: Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Tamoxifen	2021